51043-75-5

Basic information

• Product Name: 2,3-BIS(CHLOROMETHYL)-PYRAZINE
• Synonyms: 2,3-BIS(CHLOROMETHYL)-PYRAZINE;Pyrazine, 2,3-bis(chloroMethyl)-
• CAS NO: 51043-75-5
• Molecular Formula: C₆H₆Cl₂N₂
• Molecular Weight: 177.03124
• Mol File: 51043-75-5.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2,3-BIS(CHLOROMETHYL)-PYRAZINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-BIS(CHLOROMETHYL)-PYRAZINE(51043-75-5)
• EPA Substance Registry System: 2,3-BIS(CHLOROMETHYL)-PYRAZINE(51043-75-5)

Safety Data

• Hazardous Substances Data: 51043-75-5(Hazardous Substances Data)

Usage

General Description

2,3-Bis(chloromethyl)-pyrazine is a chemical compound that consists of a pyrazine ring with two chloromethyl groups attached at the 2 and 3 positions. It is commonly used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. 2,3-BIS(CHLOROMETHYL)-PYRAZINE is known for its ability to undergo nucleophilic substitution reactions, making it a versatile intermediate in organic synthesis. It is also used as a reagent in the preparation of various heterocyclic compounds and is a valuable tool for medicinal chemistry research. Additionally, 2,3-Bis(chloromethyl)-pyrazine has potential applications in the development of new materials and functional molecules.

Upstream product

• 5910-89-4 2,3-dimethylpyrazine 

Relevant articles and documents

ARYL ANNULATED MACROCYCLIC INDOLE DERIVATIVES

The present invention relates to aryl annulated macrocyclic indole derivatives of general formula (I): in which R1, R2, R3, R4, R5, R6, A and L are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of hyperproliferative disorders, as a sole agent or in combination with other active ingredients.

Keratinocyte growth inhibitors and hydroxamic acid derivatives

This invention relates to a keratinocyte-proliferation inhibitor comprising as active ingredient a compound having an activity of inhibiting the solubilization of heparin-binding EGF-like growth factor bound to cell membranes and a compound of the formula (I); or pharmaceutically acceptable salt thereof, wherein R1, R2, R3 are hydrogen atom or alkyl and X is substituted benzene or the like.

-Methyl Functionalization of Electron-Poor Heterocycles: Free Radical Chlorination

-